Faster diagnosis for deadly blood disease? new test in trial
NCT ID NCT05046717
Summary
This study aims to validate a new, automated blood test for diagnosing and monitoring acquired Thrombotic Thrombocytopenic Purpura (aTTP), a rare and life-threatening blood disorder. It will involve up to 500 patients in Spain and Portugal to see if the new test is as accurate as current methods but faster and easier to use. The goal is to help doctors diagnose this urgent condition more quickly and reliably to guide proper treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centro Hospitalar e Universitario de Coimbra
Coimbra, Coimbra District, 3004-561, Portugal
-
Complejo Hospitalario Universitario A Coruña
A Coruña, A Coruña, 15006, Spain
-
Hospital Clinic de Barcelona
Barcelona, Spain
-
Hospital Clínico San Carlos
Madrid, Spain
-
Hospital Gregorio Marañon
Madrid, Spain
-
Hospital La Fe de Valencia
Valencia, Spain
Conditions
Explore the condition pages connected to this study.